CME Presentations

Emerging Diagnostics


Presentations


Speakers

  • Andrew Hudnut, MD

    Andrew Hudnut, MD

    Andrew Hudnut, MD

    Family Medicine Specialist

  • Tomasz (Tom) Beer, MD, FACP

    Tomasz (Tom) Beer, MD, FACP

    Tomasz (Tom) Beer, MD, FACP

    Professor of Medicine, Hematology & Medical Oncology

    Tomasz Beer, MD, FACP, is professor of medicine and Grover C. Bagby Endowed Chair for Prostate Cancer Research in the Division of Hematology & Medical Oncology at Oregon Health & Science University (OHSU) in Portland, where he leads the Prostate Cancer Research Program. He has authored or co-authored more than 250 peer reviewed articles on prostate cancer. Dr Beer is known for investigations of targeted therapies and immunotherapies in prostate cancer, including vitamin D receptor, the androgen receptor, and clustering targeting agents. He serves as deputy director of OHSU Knight Cancer Institute and the National Cancer Institute designated Comprehensive Cancer Center, and chief medical officer for the Center for Early Detection Advanced Research of the Knight Cancer Institute.
  • Catherine Marinac, PhD

    Catherine Marinac, PhD

    Catherine Marinac, PhD

    Member of Faculty, Division of Population Sciences


CME Information

The Cancer Check-Up: Early Detection Using Multi-Cancer Screening


PIM Logo PQH Logo

LEARNING OBJECTIVES

After completing this activity, the participant should be better able to:
  • Discuss the value of multi-cancer screening testing in reducing cancer morbidity and mortality through earlier detection across a broad range of tumor types
  • Evaluate recent clinical data on emerging non-invasive multi-cancer screening tests and their clinical utility in early cancer detection
  • Discuss considerations for the integration of multi-cancer screening testing into patient care and workflow in the primary care setting
  • Counsel patients to mitigate barriers to multi-cancer screening tests and discuss clinical decision options based on results
Jointly provided by Postgraduate Institute for Medicine and PlatformQ Health Education, LLC.

ACKNOWLEDGEMENT

Supported by an educational grant from GRAIL Inc.

TUITION

Complimentary

JointlyAccreditedProvider Logo

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

LIVE CREDIT DESIGNATION STATEMENT

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ENDURING CREDIT DESIGNATION STATEMENT

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DATE OF RELEASE/EXPIRATION

Live Activity

Thursday, July 22, 2021 at 12:00 – 1:00 pm EST

Enduring Material

July 22, 2021 – July 22, 2022.

TARGET AUDIENCE

The intended audience for this activity program are primary care physicians, internists, family physicians, nurses, physician assistants and nurse practitioners in primary care practices.

ESTIMATED TIME TO COMPLETE

This activity should take approximately 1 hour to complete.

METHOD OF PARTICIPATION

There are no fees to participate in this activity. To participate in the activity, go to www.OMedLive.com or www.ClinicalSeriesLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

DISCLOSURE OF CONFLICTS OF INTEREST

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Financial Relationship
Catherine R. Marinac, PhD
Assistant Professor of Medicine
Dana-Farber Cancer Institute
Boston MA
Consulting Fees (e.g., advisory boards): JFB Legal
Contracted Research: GRAIL
Andrew Hudnut, MD
Family Medicine Specialist
Vice President of Elk Grove
Sutter Medical Group Division
Consulting Fees (e.g., advisory boards): Primary Care Provider to GRAIL
Contracted Research: Pathfinder Clinical Trial
Dr. Tomasz (Tom) M. Beer, MD, FACP
Professor of Medicine, Deputy Director
Grover C. Bagby Endowed Chair for Prostate Cancer Research
Deputy Director, OHSU Knight Cancer Institute
Chief Medical Officer, CEDAR
Professor of Medicine, Hematology & Medical Oncology
Director, Prostate Cancer Research Program
Oregon Health & Science University
Portland, Oregon
Consulting Fees (e.g., advisory boards): Arvinas, Astellas Pharma, AstraZeneca, Bayer, Bristol-Myers Squib, Constellation, Grail Inc., Janssen, Myovant Sciences, Pfizer, Sanofi
Contracted Research: Alliance Foundation Trials, Astellas Pharma, Bayer, Boehringer Ingelheim, Corcept Therapeutics, Endocyte Inc./Advanced Accelerator Applications (AAA), Freenome, Grail Inc., Harpoon Therapeutics, Janssen Research & Development, Medivation, Inc., Sotio, Theraclone Sciences/Onco Response, Zenith Epigenetics

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Financial Relationship
Tariqa Ackbarali
Medical Director
PlatformQ Health Education, LLC
None

The PIM planners and managers have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Bridget Griffin, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support: Please contact the Postgraduate Institute for Medicine at inquiries@pimed.com.

Technical Support: For any technical issues or issues with your CME Certificate, please contact ClinicalSeriesLive at 877-394-1306 or at Support@ClinicalSeriesLive.com.